Salignostics Closes $8M Funding Round to Take Its Saliva-Based Pregnancy Test to Market
Salignostics, a Jerusalem medical startup, has raised $8 million in a Series A financing round in order to mass market their rapid saliva-based test kits.
Nectin Therapeutics Obtained $5.4 Million Investment for Solid Tumors Immunotherapy Study
Nectin Therapeutics Ltd., a biotechnology company developing novel targeted immunotherapies, and Cancer Focus Fund, LP, a unique investment fund established in collaboration with The University
NewStem Files FDA Pre-Submission & EMA IVDD for Revolutionary Cancer Diagnostic Device
NewStem Ltd filed for a pre-submission to the FDA for a De Novo Request and an in vitro cancer diagnostic device (IVDD) to the EMA
Nanox Opens So. Korean Fab Plant to Produce Semiconductor Chips for Novel Digital Nanox.ARC 3D X-Ray System
Nanox (Nasdaq/TASE: ), an Israeli corporation that has developed the first solid-state digital X-ray source designed to be used in real-world medical imaging applications, has
Oramed Granted NASH Patent in Europe
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that the European Patent Office
Synthetic Biology Startup Seevix Material Sciences Starts Global Marketing Campaign for its Tissue Engineering Scaffold
HUMAN TISSUE REGENERATION IS SEEVIX’S ULTIMATE GOAL Seevix Material Sciences Ltd. is a privately-held biotech company producing high-strength SVX™, a state-of-the-art biopolymer material, inspired by
BiondVax Signs Expanded Agreement with Max Planck Society to Develop Nanosized Antibody Therapies
BiondVax Pharmaceuticals Ltd. (Nasdaq:BVXV), a Jerusalem based biopharmaceutical company focused on developing, manufacturing, and commercializing innovative products for the prevention and treatment of infectious diseases
BactoByte Develops Life-Saving Blood Diagnostic with Quick-1- Hour Turnaround
BactoByte is developing a conceptually new laboratory system that will process a line of assays, delivering clinical-grade results in medical (blood, urine, swabs, spinal fluid),
Terrapeutics Signs Agreement with HIPS to Co-Develop Novel Antibiotics to Treat Incurable Cancers
Terrapeutics Pharma (“Terrapeutics”) and the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) are pleased to announce that they have reached a cooperation agreement to co-develop novel
